Repurposing approved drugs on the pathway to novel therapies-Reference-Cited by-同舟云学术

Repurposing approved drugs on the pathway to novel therapies

Published:2020-03 Issue:2 Volume:40 Page:586-605
ISSN:0198-6325
Container-title:Medicinal Research Reviews
language:en
Short-container-title:Med Res Rev

Author:

Schein Catherine H.¹^ORCID

Affiliation:

1. Department of Biochemistry and Molecular Biology, Institute for Human Infection and Immunity (IHII)University of Texas Medical Branch at GalvestonGalveston Texas

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Wiley

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/med.21627

Reference179 articles.

1. Inhibition of adenovirus infection by mifepristone

2. Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection

3. Repurposing drugs for use against Zika virus infection

4. Novel approaches to flavivirus drug discovery

5. Identification of a Compound That Disrupts Binding of Amyloid-β to the Prion Protein Using a Novel Fluorescence-based Assay

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing FDA-approved disulfiram for targeted inhibition of diphtheria toxin and the binary protein toxins of Clostridium botulinum and Bacillus anthracis;Frontiers in Pharmacology;2024-09-13

2. Emergence of resistance to the antiparasitic selamectin inMycobacterium smegmatisis improbable and contingent on cell wall integrity;2024-09-05

3. Discovery of putative inhibitors of human Pkd1 enzyme: Molecular docking, dynamics and simulation, QSAR, and MM/GBSA;Environmental Research;2024-09

4. S-(N,N-diethyldithiocarbamoyl)-N-acetyl- l -cysteine for the treatment of non-small cell lung cancer through regulating NF-κB signalling pathway without neurotoxicity;Journal of Drug Targeting;2024-07-12

5. Use of Drug Sensitisers to Improve Therapeutic Index in Cancer;Pharmaceutics;2024-07-11